What's fueling the biotech engine--2008
- PMID: 19898448
- DOI: 10.1038/nbt1109-987
What's fueling the biotech engine--2008
Abstract
Despite the global economic slowdown, biologics managed single-digit growth in 2008, driven mainly by continued high growth in sales of antibodies and insulins. Novel biologics in development look promising, but crowding, pricing and reimbursement are emerging as longer-term concerns.
References
MeSH terms
LinkOut - more resources
Full Text Sources
